Ashique Rafique

7.4k citations
39 papers · 2.6k · 2 hit papers · h-index 19

Impact in

Papers in

Ashique Rafique

34 papers receiving 2.5k citations

Ashique Rafique's Hit Papers

Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation 2019 · 349 citations
3490+4+9Years since publication250500750

Peers

Ashique Rafique
Comparison fields: 5 of 105
  • Ophthalmology 577
  • Radiology, Nuclear Medicine and Imaging 551
  • Immunology and Allergy 114
  • Oncology 370
  • Otorhinolaryngology 58
Replace Qing Lü with:
Qing Lü China
Zishan A. Haroon United States
Luis de la Cruz‐Merino Spain
Jun Guo China
Samia Mourah France
W. J. Mooi Netherlands
Peter Vermeulen Belgium
Emanuela Romano France
Yasuo Saijo Japan
Makoto Saegusa Japan
Ashique Rafique relative to Qing Lü China Qing Lü's profile →
Citations per field
00.5×6.7×
Qing Lü · 1×
Citations per year

Countries citing papers authored by Ashique Rafique

Since Specialization
Citations

This map shows the geographic impact of Ashique Rafique's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashique Rafique with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashique Rafique more than expected).

Fields of papers citing papers by Ashique Rafique

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashique Rafique. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashique Rafique. The network helps show where Ashique Rafique may publish in the future.

Co-authors

The 25 scholars most cited alongside Ashique Rafique, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ashique Rafique Line = papers co-authored together Ashique Rafique links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab
Hit paper breakdown →
2012843
2
Dual blockade of IL‐4 and IL‐13 with dupilumab, an IL‐4Rα antibody, is required to broadly inhibit type 2 inflammation
Hit paper breakdown →
2019349
3 2002191
4 2015173
5 2017141
6 2017137
7 2015117
8 201794
9 201580
10 201964
11 202049
12 201446
13 202034
14 201328
15 202326
16 202026
17 201924
18 201924
19 201718
20 202015

About Ashique Rafique

Ashique Rafique is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Immunology, Surgery and Oncology, having authored 39 papers that have together received 2.6k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (12 papers), Protein purification and stability (6 papers), Angiogenesis and VEGF in Cancer (4 papers), IL-33, ST2, and ILC Pathways (3 papers), Immunotherapy and Immune Responses (3 papers), Muscle Physiology and Disorders (3 papers), Advanced Biosensing Techniques and Applications (3 papers) and Retinal Diseases and Treatments (3 papers). The work is most often cited by research in Ophthalmology (577 citations), Radiology, Nuclear Medicine and Imaging (551 citations), Immunology and Allergy (114 citations), Oncology (370 citations) and Otorhinolaryngology (58 citations). Ashique Rafique has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include George D. Yancopoulos, Joel Martin, Nicholas Papadopoulos, Neil Stahl, Ergang Shi, Erica Pyles, Michael Rosconi, Stanley J. Wiegand, Qin Ruan and Vishal Kamat. Their work appears in journals such as Analytical Biochemistry, Nature Communications, Molecular Cancer Therapeutics, Bioanalysis and Investigative Ophthalmology & Visual Science.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact